Work

Drug Coated Balloon in Young Patients With ST‐Elevation Myocardial Infarction: A Viable Treatment Option?

Year: 2025

Type: article

Abstract: This clinical case highlights the safety and feasibility of drug coated balloon (DCB) angioplasty in a very young patients presenting with STEMI (ST-Elevation Myocardial Infarction) to avoid long-term complications associated with stent implantation, which still amount to 1%-2%. We successfully treated a 25 years old patient with occluded right coronary artery (RCA) with DCB after careful lesion preparation. Moreover, in a control angiogram 7 weeks later the RCA was patent with substantial lumen enlargement of 0.4 mm (RAO projection) to almost 2 mm (LAO projection) in a very short period of time. DCB angioplasty offers a viable alternative to stent implantation in young patients, avoiding the complications associated with permanent metallic implants while promoting vascular remodeling. While we acknowledge that more evidence is needed to optimize patient selection and confirm the long-term benefits of DCB in ACS, this case highlights its efficacy and safety in terms of an individualized treatment strategy.

Source: Catheterization and Cardiovascular Interventions

DOI: 10.1002/ccd.31699

Authors: Davor Vukadinović, Saarraaken Kulenthiran, Felix Mahfoud, Bruno Scheller

Institutions: Universitätsklinikum des Saarlandes, University Hospital of Basel, Massachusetts Institute of Technology, Saarland University

Language: English

Topic: Coronary Interventions and Diagnostics

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,490